NFlection Therapeutics Funding: $24M Raised, Series A (2020)
NFlection Therapeutics is based in Boston, MA. It has raised $24M in total funding. Latest round: Series A.
NFlection Therapeutics funding overview
NFlection Therapeutics is based in Boston, MA. NFlection Therapeutics has raised $24M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in July 2020. The round record for NFlection Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include venBio Partners, F-Prime Capital, Children’s Tumor Foundation. 3 distinct backers are named across the disclosed rounds.
NFlection Therapeutics at a glance
Total raised
$24M
Latest round
Series A
Latest round date
July 2020
Headquarters
Boston, MA
Notable investors
venBio Partners, F-Prime Capital, Children’s Tumor Foundation
Frequently asked about NFlection Therapeutics funding
How much has NFlection Therapeutics raised?
NFlection Therapeutics has raised $24M in total disclosed funding across the rounds on record.
Who has invested in NFlection Therapeutics?
venBio Partners, F-Prime Capital, Children’s Tumor Foundation are named among the investors backing NFlection Therapeutics.
What was the latest NFlection Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2020.
Where is NFlection Therapeutics based?
NFlection Therapeutics is based in Boston, MA.
When did NFlection Therapeutics last raise?
The last disclosed NFlection Therapeutics round closed in July 2020 at Series A.
Totals shown for NFlection Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
